Jump Financial, LLC Compugen LTD Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.57 - $3.33 $75,674 - $160,506	-48,200 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.76 - $4.64 $105,073 - $176,644	38,070 Added 375.81%	48,200 $155,000
Q4 2021 Feb 10, 2022	BUY	$4.09 - $7.16 $41,431 - $72,530	10,130 New	10,130 $44,000
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $271,985 - $376,089	-46,894 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.87 - $9.16 $42,490 - $56,654	-6,185 Reduced 11.65%	46,894 $389,000
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $34,353 - $61,675	4,479 Added 9.22%	53,079 $456,000
Q4 2020 Feb 12, 2021	BUY	$12.07 - $17.95 $586,602 - $872,370	48,600 New	48,600 $589,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $139M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.